ArticleClinical and translational radiation oncology2025

Short-term survivors with brain metastases have modest benefits from focal and systemic therapies and remain frequent despite improving treatment landscape.

M Czogalla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.